©2013 Baishideng Publishing Group Co.
World J Clin Cases. Nov 16, 2013; 1(8): 249-255
Published online Nov 16, 2013. doi: 10.12998/wjcc.v1.i8.249
Published online Nov 16, 2013. doi: 10.12998/wjcc.v1.i8.249
Table 2 Distribution and bacteria isolated at control and test sites at baseline, 5 and 13 wk n (%)
| Baseline | 5 wk | 13 wk | ||||
| Control | Test | Control | Test | Control | Test | |
| Actinomycesnaeslundii FG+veR | 3 (3.9) | - | - | - | 1 (1.7) | 1 (1.6) |
| Actinomycesviscosus FG+veR | 2 (2.6) | - | - | - | 1 (1.7) | 1 (1.6) |
| Bifidobacterium spp FG+veR | 4 (5.2) | 3 (7.1) | 2 (4) | 2 (3.6) | 1 (1.7) | 3 (4.9) |
| Clostridium spp FG+veR | - | - | 7 (14) | 6 (11.3) | - | - |
| Diphtheroid bacilli AG+veR | 2 (2.6) | 4 (9.5) | 2 (4) | 2 (3.6) | 3 (5.3) | 1 (1.6) |
| Escherichia coli FG-veR | - | - | 1 (2) | 2 (3.6) | - | - |
| Eubacterium spp FG+veR1 | 1 (1.3) | - | - | 2 (3.6) | - | - |
| Fusobacteriumnucleatum AnG-veR1 | 2 (2.6) | - | 3 (6) | 4 (7.5) | 8 (14.2) | - |
| Haemophilus spp FG-veR | 10 (13.1) | 3 (7.1) | 4 (8) | 2 (3.6) | 5 (8.9) | 3 (4.9) |
| Coagulase-negative Staphylococci FG+veC | 2 (2.6) | 2 (4.7) | 2 (4) | 1 (1.8) | - | 4 (6.5) |
| Neisserria spp AG-veC | 8 (10.5) | 2 (4.7) | 2 (4) | 2 (3.6) | 1 (1.7) | - |
| Peptostreptococcus AnG+veC | 5 (6.5) | - | - | - | - | - |
| Porphyromonasgingivalis AnG-veR1 | - | - | - | - | 2 (3.2) | - |
| Prevotellaintermedia AnG-veR1 | 1 (1.3) | 1 (2.3) | 1 (2) | 1 (1.8) | 8 (14.2) | - |
| Propionibacteriumgranulosum FG+veR | - | 1 (2.3) | - | - | - | - |
| Staphylococcus aureus FG+veC | 2 (2.6) | 1 (2.3) | 3 (6) | 7 (13.2) | - | 2 (3.2) |
| Veillonellaparvula AnG-veC1 | 1 (1.3) | 1 (2.3) | 3 (6) | 1 (1.8) | 10 (17.8) | 1 (1.6) |
| Streptococci AG-veC | 25 (32.8) | 15 (35.7) | 15 (30) | 19 (35.8) | 11 (19.6) | 39 (63.9) |
| Campylobacter rectus FG-veR | 6 (7.8) | 4 (9.5) | 3 (6) | - | 4 (7.1) | 2 (3.2) |
| Treponemadenticola AnG-veC1 | 1 (1.3) | 2 (4.7) | 1 (2) | 1 (1.8) | - | - |
| Gemella spp FG+veC | - | - | - | - | 2 (3.2) | |
| Filifactoralocis FG+veR | 1 (1.3) | 3 (7.1) | 1 (2) | 1 (1.8) | 1 (1.7) | 2 (3.2) |
| Total (n) | 76 | 42 | 50 | 53 | 56 | 61 |
| P value | 0.595 | 0.895 | 0.0062 | |||
- Citation: Saini M, Singh Y, Garg R, Pandey A. Priming the tooth surface with chlorhexidine and antibacterial activity of resin cement. World J Clin Cases 2013; 1(8): 249-255
- URL: https://www.wjgnet.com/2307-8960/full/v1/i8/249.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v1.i8.249